Been watching it on and off for 2 years Alpha, fundamentals are/were good, execution woeful, even 6 month chart looks like a one way slide into the abyss.
Macquarie advised private clients in september of a 12 month price target on the stock of just 21c (based on NTA methodology), Baker Young placed it on spec list, but recent resignation of ceo places risk at a premium.